This message contains images. If you don't see images, click here to view.
Advertise in this news brief.



  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit |  Histology Marketplace:     

Home   History   Meeting Calendar   Career Center   Certification   Contact Us    



 




TOP STORIES

Oncologists call for industry-led global fund to fight cancer
Reuters
The world faces a rapidly growing burden of cancer which will overwhelm governments unless the medical and pharma industry takes the lead on a multibillion dollar private-public fund, oncologists said. In a report on how rates of cancer diagnosis and death are rising across the world while access to diagnosis and treatment is extremely patchy, experts described the economics of the problem as daunting and current financing models as broken.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




New research offers potential to advance personalized treatment of neurological disease
HealthCanal
New research led by Dr. Matthew Hebb of Western University and the Lawson Health Research Institute, has demonstrated for the first time, how small brain biopsies may be used to grow large numbers of cells that could possibly be transplanted back into the patient's own brain. This could prove beneficial in treating various neurological disorders such as Parkinson's disease, Alzheimer's disease and Multiple Sclerosis, as well as injuries of the nervous system such stroke or traumatic brain and spinal cord injuries.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


Researchers unveil findings on two new weapons against thyroid cancer
Medical Xpress
For many years, patients with advanced thyroid cancer faced bleak prospects and no viable treatment options. But now, building on recent discoveries about the genetics and cell signaling pathways of thyroid tumors, researchers are developing exciting new weapons against the disease, using kinase inhibitors that target tumor cell division and blood vessels. Two recent clinical trials led by a researcher from the Perelman School of Medicine at the University of Pennsylvania showcase the great promise of these new approaches.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Stanford scientists build a microscope to spot the seeds of cancer
Standford Report
The rule of thumb with cancer is that the earlier you can detect the disease, the more effective the treatment, and hence better potential outcomes. Currently, doctors draw a patient's blood and analyze it using special antibodies to detect the presence of the seeds, called circulating tumor cells. This method works well if CTCs are present in large numbers, but may fail to detect smaller numbers released by earlier tumors. Now, a team of engineers, scientists, and doctors from Stanford is developing a mini-microscope that might be able to noninvasively detect the CTCs earlier than ever, allowing for earlier interventions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




New hope for treating cancer? Patterns seen in 12 types of tumors
Los Angeles Times
Examining the molecular profiles of tumors from 12 different types of cancers, scientists working with the National Institutes of Health-backed Cancer Genome Atlas said they had found striking similarities between tumors originating in different organs. Their discoveries, made possible by improvements in sequencing technologies and computing methods, could herald a day when cancers are treated based on their genetic profiles, rather than on their tissue of origin, said UC Santa Cruz biomolecular engineer Josh Stuart.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
Stellaris RNA FISH Probes


Stellaris RNA FISH is a new research technology that enables direct detection, localization and quantification of RNA. The low cost per assay, simple protocol, and the ability to localize mRNA and lncRNA to organelles and cellular structures provides obvious benefits for life science research. Custom and catalogued probes sets available. MORE
ergoCentric Laboratory Seating

Visit LabStorage System’s updated website to view details about this new laboratory seating with specially formulated Infection Control coating. Non-porous and easily disinfected, this moisture proof coating is anti-bacterial, anti-fungal and stain resistant. more
Spring Bioscience - BRAF V600E


Spring Bioscience is leading the research industry by pioneering novel, next generation antibodies that can differentiate mutant and normal protein, enabling pathologists to see relevant mutations within their cellular context. Having already released Exon19 and EGFR L858R for exclusive use by Ventana Medical Systems, Spring Bioscience has launched BRAF V600E.
Click here to find out more.


IN THE NEWS


Inspired by the human eye, imaging system detects disease, hazardous substances
R&D Magazine
For hundreds of years, optical devices like telescopes and microscopes have relied on solid lenses that slide up and down to magnify and to focus. To tune how much light is received, conventional devices use mechanical contraptions like the blades that form the adjustable aperture in cameras. To meet demands for ever smaller imaging systems, researchers are working to create entirely unconventional ways of focusing light.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Mexican scientists reveal aflatoxins relationship with cervical and liver cancer in humans
The Medical News
Mexican scientists identified and quantified the amount of aflatoxins (carcinogenic) in food such as corn tortilla, rice, chili pepper, processed sauces, chicken breast and eggs, and revealed its relationship with cervical and liver cancer in humans. The research won the National Award in Food Science and Technology in the Science Professional in Foods category organized jointly by National Council of Science and Technology and the Mexican Coca-Cola Industry. It explains that both types of cancer can be originated by the ingestion of food contaminated with aflatoxins produced by the fungi Aspergilus flavus and A. parasiticus.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Fully Automated RNA-ISH Assays
QuantiGene® ViewRNA RX Assays – designed for use with Leica BOND RX automated IHC and ISH staining platform. Visualize single RNA molecule/cell in FFPE samples. See how.
Produce the best IHC results

Download your IHC application guide and discover reagents to support every stage of your IHC workflow. Visit Abcam at Booth 4 at ECP 2013. DOWNLOAD NOW


Medical: Flu vaccine gets a shot of innovation in design, delivery
The Republic
Until 2003, there was only the flu shot. A needle into the arm delivered vaccine, and a couple of weeks later your immune system was primed to fight off the top three strains of influenza likely to be floating around that winter and early spring. But over the past several years, flu vaccine developers and manufacturers have been doing a lot of tinkering. They've come up with at least seven different types of vaccine and/or delivery modes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Capturing cancer: Liquid biopsy could improve cancer diagnosis and treatment
Phys.org
A microfluidic chip developed at the University of Michigan is among the best at capturing elusive circulating tumor cells from blood — and it can support the cells' growth for further analysis. The device, believed to be the first to pair these functions, uses the advanced electronics material graphene oxide. In clinics, such a device could one day help doctors diagnose cancers, give more accurate prognoses and test treatment options on cultured cells without subjecting patients to traditional biopsies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword TUMORS.


  FEATURED COMPANIES
Intelsint Vacuum Tissue Processors
A line of TPs capable to conveniently cover the needs of every Histology lab. Our attention is focused on reliability, flexibility, ease of usage, samples protection and user safety.

Please visit us at www.intelsint.it
Sakura Smart Automation
Our singular focus is to optimize histology workflow. Rapid tissue-processing, Automated Embedding, and real-time specimen review are just a few of our many innovations.


'Jekyll-and-Hyde' protein may be the key to stopping cancer metastasis
Fox News
One of the deadliest aspects of a cancerous tumor is its ability to grow and spread, assimilating and destroying healthy cells throughout the body. Controlling this lethal expansion, known as metastasis, can be a difficult endeavor. But now, researchers have revealed that a notoriously fickle protein may be the key to stopping cancer's rapid development.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Winners of the Leadership, Education, Advocacy Award announced (NSH)
New imaging test for multiple sclerosis developed at Case could help speed up new treatments (The Plain Dealer)
New method for analyzing gene expression in single cells opens a window into tumors ( Ludwig Institute for Cancer Research via Medical Xpress)
Specific sugar molecule causes growth of cancer cells (Oncology Nurse Advisor)
Study: Mucus protects uterine and pancreatic cancer cells (UPI)

Don't be left behind. Click here to see what else you missed.


Genetic cause of childhood leukemia uncovered
Oncology Nurse Advisor
"We're in unchartered territory," said study author Kenneth Offit, MD, MPH, chief of the Clinical Genetics Service at Memorial Sloan-Kettering Cancer Center in New York, New York. "At the very least this discovery gives us a new window into inherited causes of childhood leukemia. More immediately, testing for this mutation may allow affected families to prevent leukemia in future generations."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  PRODUCT SHOWCASES
RNAscope: Visualize Single-Copy RNA

RNAscope FFPE Assay Kits make detecting single-copy RNA easy. RNAscope works for virtually any gene in any tissue!

• Exquisite sensitivity & specificity
• Optimized for archival FFPE tissue
• Easy 7-hour IHC-like workflow
• Quantifiable and automatable
• New assays in < 3 weeks
• Guaranteed assay performance
Reduce Cost with Same Quality

GBI Labs produces the largest selection of secondary detection kits. We provide free samples to 1st time users. Staining with our kits results in similar or better sensitivity than other detection kits on the market. Some 110mL kits cost as little as $700.00 and 18 ml kit > $300.00.
To find out how to feature your company in Under the Microscope and other advertising opportunities, Contact James DeBois at 469-420-2618

More info
 

Under the Microscope
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Ashley Whipple, Senior Content Editor, 469.420.2642   
Contribute news

This edition of Under the Microscope was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Oct. 2, 2013
Sept 30, 2013 blast
Sept. 25, 2013
Sept. 20, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063